156 related articles for article (PubMed ID: 24849780)
1. A structure-property relationship study of the well-defined telodendrimers to improve hemocompatibility of nanocarriers for anticancer drug delivery.
Shi C; Yuan D; Nangia S; Xu G; Lam KS; Luo J
Langmuir; 2014 Jun; 30(23):6878-88. PubMed ID: 24849780
[TBL] [Abstract][Full Text] [Related]
2. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery.
Li Y; Xiao K; Luo J; Xiao W; Lee JS; Gonik AM; Kato J; Dong TA; Lam KS
Biomaterials; 2011 Sep; 32(27):6633-45. PubMed ID: 21658763
[TBL] [Abstract][Full Text] [Related]
3. A novel size-tunable nanocarrier system for targeted anticancer drug delivery.
Li Y; Xiao K; Luo J; Lee J; Pan S; Lam KS
J Control Release; 2010 Jun; 144(3):314-23. PubMed ID: 20211210
[TBL] [Abstract][Full Text] [Related]
4. A drug-specific nanocarrier design for efficient anticancer therapy.
Shi C; Guo D; Xiao K; Wang X; Wang L; Luo J
Nat Commun; 2015 Jul; 6():7449. PubMed ID: 26158623
[TBL] [Abstract][Full Text] [Related]
5. Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment.
Luo J; Xiao K; Li Y; Lee JS; Shi L; Tan YH; Xing L; Holland Cheng R; Liu GY; Lam KS
Bioconjug Chem; 2010 Jul; 21(7):1216-24. PubMed ID: 20536174
[TBL] [Abstract][Full Text] [Related]
6. Fine-tuning vitamin E-containing telodendrimers for efficient delivery of gambogic acid in colon cancer treatment.
Huang W; Wang X; Shi C; Guo D; Xu G; Wang L; Bodman A; Luo J
Mol Pharm; 2015 Apr; 12(4):1216-29. PubMed ID: 25692376
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer.
Lin TY; Zhang H; Luo J; Li Y; Gao T; Lara PN; de Vere White R; Lam KS; Pan CX
Int J Nanomedicine; 2012; 7():2793-804. PubMed ID: 22745542
[TBL] [Abstract][Full Text] [Related]
9. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.
Xiao K; Luo J; Li Y; Lee JS; Fung G; Lam KS
J Control Release; 2011 Oct; 155(2):272-81. PubMed ID: 21787818
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy.
Baumann BC; Kao GD; Mahmud A; Harada T; Swift J; Chapman C; Xu X; Discher DE; Dorsey JF
Oncotarget; 2013 Jan; 4(1):64-79. PubMed ID: 23296073
[TBL] [Abstract][Full Text] [Related]
11. Tumor-targeting, pH-responsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapy.
Yang X; Grailer JJ; Pilla S; Steeber DA; Gong S
Bioconjug Chem; 2010 Mar; 21(3):496-504. PubMed ID: 20163170
[TBL] [Abstract][Full Text] [Related]
12. Folding graft copolymer with pendant drug segments for co-delivery of anticancer drugs.
Tai W; Mo R; Lu Y; Jiang T; Gu Z
Biomaterials; 2014 Aug; 35(25):7194-203. PubMed ID: 24875756
[TBL] [Abstract][Full Text] [Related]
13. Block and random copolymers bearing cholic acid and oligo(ethylene glycol) pendant groups: aggregation, thermosensitivity, and drug loading.
Shao Y; Jia YG; Shi C; Luo J; Zhu XX
Biomacromolecules; 2014 May; 15(5):1837-44. PubMed ID: 24725005
[TBL] [Abstract][Full Text] [Related]
14. "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.
Xiao K; Li Y; Lee JS; Gonik AM; Dong T; Fung G; Sanchez E; Xing L; Cheng HR; Luo J; Lam KS
Cancer Res; 2012 Apr; 72(8):2100-10. PubMed ID: 22396491
[TBL] [Abstract][Full Text] [Related]
15. Multiscale approach to investigate self-assembly of telodendrimer based nanocarriers for anticancer drug delivery.
Jiang W; Luo J; Nangia S
Langmuir; 2015 Apr; 31(14):4270-80. PubMed ID: 25532019
[TBL] [Abstract][Full Text] [Related]
16. Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?
Saad M; Garbuzenko OB; Ber E; Chandna P; Khandare JJ; Pozharov VP; Minko T
J Control Release; 2008 Sep; 130(2):107-14. PubMed ID: 18582982
[TBL] [Abstract][Full Text] [Related]
17. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
Cao W; Zhou J; Mann A; Wang Y; Zhu L
Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of doxorubicin-loaded 3-helix micelles as nanocarriers.
Dube N; Shu JY; Dong H; Seo JW; Ingham E; Kheirolomoom A; Chen PY; Forsayeth J; Bankiewicz K; Ferrara KW; Xu T
Biomacromolecules; 2013 Oct; 14(10):3697-705. PubMed ID: 24050265
[TBL] [Abstract][Full Text] [Related]
19. The effect of size and polymer architecture of doxorubicin-poly(ethylene) glycol conjugate nanocarriers on breast duct retention, potency and toxicity.
Gu Z; Gao D; Al-Zubaydi F; Li S; Singh Y; Rivera K; Holloway J; Szekely Z; Love S; Sinko PJ
Eur J Pharm Sci; 2018 Aug; 121():118-125. PubMed ID: 29698706
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA.
Taratula O; Kuzmov A; Shah M; Garbuzenko OB; Minko T
J Control Release; 2013 Nov; 171(3):349-57. PubMed ID: 23648833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
